- Home
- PLCE vs PYXS Comparison
PLCE vs PYXS Comparison
Compare PLCE & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLCE | PYXS |
|---|---|---|
| Founded | 1969 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.8M | 82.3M |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PLCE | PYXS |
|---|---|---|
| Price | $3.50 | $1.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $4.50 | ★ $7.00 |
| AVG Volume (30 Days) | 228.4K | ★ 299.9K |
| Earning Date | 03-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.35 | 3.03 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $13,858,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7,043.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.95 | $0.86 |
| 52 Week High | $9.56 | $5.55 |
Technical Indicators
Market Signals| Indicator | PLCE | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 44.46 | 49.09 |
| Support Level | N/A | $1.29 |
| Resistance Level | $3.74 | $1.69 |
| Average True Range (ATR) | 0.20 | 0.11 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 65.82 | 44.32 |
Price Performance
Historical ComparisonAbout PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.